AI assistant
ABBOTT LABORATORIES — Director's Dealing 2004
Jan 2, 2004
29777_dirs_2004-01-02_9d1e1b38-fbdc-4efa-ab97-e36b06ccc551.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2003-12-31
Reporting Person: MCCULLOUGH GARY E (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2003-12-31 | Common shares without par value | A | 40000 | $46.62 | Acquired | 40000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2003-12-31 | Option (right to buy) | $46.62 | A | 100000 | Acquired | 2013-12-30 | Common shares (100000) | Direct |
Footnotes
F1: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The award includes the right to have stock withheld for tax purposes.
F2: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 33,334, 33,333, and 33,333 beginning on December 31, 2004, the first anniversary date of the grant.